107 related articles for article (PubMed ID: 38244809)
1. Trifluoromethyl quinoline derivative targets inhibiting HDAC1 for promoting the acetylation of histone in cervical cancer cells.
Zhang T; Zhou C; Lv M; Yu J; Cheng S; Cui X; Wan X; Ahmad M; Xu B; Qin J; Meng X; Luo H
Eur J Pharm Sci; 2024 Mar; 194():106706. PubMed ID: 38244809
[TBL] [Abstract][Full Text] [Related]
2. [Effect of siRNA targeting HDAC1 gene on proliferation, apoptosis, histone acetylation, and histone methylation in gastric cancer cells in vitro].
Zhuang H; Ma X; Lai Y; Xu X; Wang X
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Feb; 34(2):246-50. PubMed ID: 24589606
[TBL] [Abstract][Full Text] [Related]
3. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects.
Miao JF; Peng YF; Chen S; Gao WJ; Yang QX; Zhu P; Guo J; Tao J; Luo L; Zhang Y; Ling Y
Eur J Pharmacol; 2018 Apr; 824():78-88. PubMed ID: 29428472
[TBL] [Abstract][Full Text] [Related]
4. [Inhibitory effect of VPA on multiple myeloma U266 cell proliferation and regulation of histone acetylation].
Zhu YF; Ye BG; Shen JZ; Lin CM; Lin FA; Shen SF; Xu CB
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):638-41. PubMed ID: 20561418
[TBL] [Abstract][Full Text] [Related]
5.
Sixto-López Y; Rosales-Hernández MC; Contis-Montes de Oca A; Fragoso-Morales LG; Mendieta-Wejebe JE; Correa-Basurto AM; Abarca-Rojano E; Correa-Basurto J
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824279
[No Abstract] [Full Text] [Related]
6. HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells.
Song KH; Choi CH; Lee HJ; Oh SJ; Woo SR; Hong SO; Noh KH; Cho H; Chung EJ; Kim JH; Chung JY; Hewitt SM; Baek S; Lee KM; Yee C; Son M; Mao CP; Wu TC; Kim TW
Cancer Res; 2017 Sep; 77(18):5039-5053. PubMed ID: 28716899
[TBL] [Abstract][Full Text] [Related]
7. Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line.
Yagi Y; Fushida S; Harada S; Kinoshita J; Makino I; Oyama K; Tajima H; Fujita H; Takamura H; Ninomiya I; Fujimura T; Ohta T; Yashiro M; Hirakawa K
J Exp Clin Cancer Res; 2010 Nov; 29(1):149. PubMed ID: 21080974
[TBL] [Abstract][Full Text] [Related]
8. Discovery of 1,2,4-oxadiazole-Containing hydroxamic acid derivatives as histone deacetylase inhibitors potential application in cancer therapy.
Yang Z; Shen M; Tang M; Zhang W; Cui X; Zhang Z; Pei H; Li Y; Hu M; Bai P; Chen L
Eur J Med Chem; 2019 Sep; 178():116-130. PubMed ID: 31177073
[TBL] [Abstract][Full Text] [Related]
9. Steroid receptor coactivator-3 is a pivotal target of gambogic acid in B-cell Non-Hodgkin lymphoma and an inducer of histone H3 deacetylation.
Zhao Z; Zhang X; Wen L; Yi S; Hu J; Ruan J; Zhao F; Cui G; Fang J; Chen Y
Eur J Pharmacol; 2016 Oct; 789():46-59. PubMed ID: 27370960
[TBL] [Abstract][Full Text] [Related]
10. A novel aromatic amide derivative SY-65 co-targeted tubulin and histone deacetylase 1 with potent anticancer activity in vitro and in vivo.
Li YR; Liu FF; Liu WB; Zhang YF; Tian XY; Fu XJ; Xu Y; Song J; Zhang SY
Biochem Pharmacol; 2022 Jul; 201():115070. PubMed ID: 35526597
[TBL] [Abstract][Full Text] [Related]
11. 8a, a New Acridine Antiproliferative and Pro-Apoptotic Agent Targeting HDAC1/DNMT1.
Zhang Q; Wang Z; Chen X; Qiu H; Gu Y; Wang N; Wang T; Wang Z; Ma H; Zhao Y; Zhang B
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073721
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting of retinoid X receptor and histone deacetylase with DW22 as a novel antitumor approach.
Wang L; Chen G; Chen K; Ren Y; Li H; Jiang X; Jia L; Fu S; Li Y; Liu X; Wang S; Yang J; Wu C
Oncotarget; 2015; 6(12):9740-55. PubMed ID: 25762635
[TBL] [Abstract][Full Text] [Related]
13. LSD1 regulates pluripotency of embryonic stem/carcinoma cells through histone deacetylase 1-mediated deacetylation of histone H4 at lysine 16.
Yin F; Lan R; Zhang X; Zhu L; Chen F; Xu Z; Liu Y; Ye T; Sun H; Lu F; Zhang H
Mol Cell Biol; 2014 Jan; 34(2):158-79. PubMed ID: 24190971
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of antiproliferative action of a new d-secoestrone-triazole derivative in cervical cancer cells and its effect on cancer cell motility.
Bózsity N; Minorics R; Szabó J; Mernyák E; Schneider G; Wölfling J; Wang HC; Wu CC; Ocsovszki I; Zupkó I
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt B):247-257. PubMed ID: 27363663
[TBL] [Abstract][Full Text] [Related]
15. Elevated histone H3 acetylation and loss of the Sp1-HDAC1 complex de-repress the GM2-synthase gene in renal cell carcinoma.
Banerjee A; Mahata B; Dhir A; Mandal TK; Biswas K
J Biol Chem; 2019 Jan; 294(3):1005-1018. PubMed ID: 30463940
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of MDA-MB-231 breast cancer cell proliferation and tumor growth by apigenin through induction of G2/M arrest and histone H3 acetylation-mediated p21
Tseng TH; Chien MH; Lin WL; Wen YC; Chow JM; Chen CK; Kuo TC; Lee WJ
Environ Toxicol; 2017 Feb; 32(2):434-444. PubMed ID: 26872304
[TBL] [Abstract][Full Text] [Related]
17. HDAC1 and HDAC2 Double Knockout Triggers Cell Apoptosis in Advanced Thyroid Cancer.
Lin CL; Tsai ML; Lin CY; Hsu KW; Hsieh WS; Chi WM; Huang LC; Lee CH
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30669676
[TBL] [Abstract][Full Text] [Related]
18. [Inhibitory effect of trichostatin A on HepG2 cell proliferation and the mechanisms].
Shi Q; Zuo G; Feng Z; Zhao L; Luo N; You Z; Xia J; Li D; Li J; Chen D
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):917-22. PubMed ID: 25057056
[TBL] [Abstract][Full Text] [Related]
19. Histone Deacetylation Regulated by KDM1A to Suppress DACT1 in Proliferation and Migration of Cervical Cancer.
Zeng L; Chen C; Yao C
Anal Cell Pathol (Amst); 2021; 2021():5555452. PubMed ID: 34350095
[TBL] [Abstract][Full Text] [Related]
20. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]